|
|
| |
|
According to the National Academy of Clinical Biochemistry guidelines for the use of cardiac markers in coronary artery disease, troponin I is definitive of acute myocardial infarction. The new Access AccutnI assay was designed for rapid turnaround and improved sensitivity and specificity, helping laboratories meet a new standard of care in the management of patients with cardiac disease.
|
| |
| Features |
 |
| |
Speed and Ease-of-Use Improve Efficiency
-
Time to result of 12 minutes allows laboratories to deliver results in
less than 30 minutes from sample draw.
-
The assay uses the preferred sample type, heparinized plasma, for rapid
sample processing.
-
Stable, liquid calibrators and controls improve ease of use.
-
A curve stability of 56 days reduces both time required for calibration
and the costs associated with calibration, while providing the technical
benefits of multi-point calibration.
|
|
Reliable Results for Greater Confidence
-
Antibodies specific to the stable region of the cTnI molecule improve
sample integrity and increase reliability of results.
-
Minimal response to heterophile interferences increases confidence in
results, reducing delays associated with repeat analysis.
-
Excellent clinical sensitivity and specificity reduces laboratory
consultation with physicians.
|
|
|
|
|
| |
| |
| Ordering
Information |
| |
| Name |
Description |
Part Type |
Part Number |
| Access Troponin I Control QC |
3 levels, 6 x 2.5 mL |
Control |
33349 |
| Access Troponin I |
2 packs of 50 tests/pack |
Reagent |
33340 |
| Access Troponin I Calibrators |
1 set of 6 x 1 mL |
Calibrator |
33345 |
|
| |
|
|
| |
|
| |
|
| |
| |
|
|
|
